Atrial fibrillation in ischemic stroke: Predicting response to thrombolysis and clinical outcomes

Stroke

Volumn 44, Issue 1, 2013, Pages 99-104

  Saposnik, Gustavo ^a,b,c,e   Gladstone, David ^a   Raptis, Roula ^b   Zhou, Limei ^c   Hart, Robert G ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

atrial fibrillation; iScore; outcomes; risk assessment; stroke; stroke care; thrombolysis

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DISABILITY; DISEASE ASSOCIATION; FEMALE; FUNCTIONAL STATUS; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANKIN SCALE; RISK FACTOR; STROKE PATIENT; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CANADA; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGISTRIES; STROKE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 84872086748     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.676551     Document Type: Article

References (31)

1. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:517-584.
2. Stroke Risk in Atrial Fibrillation Working Group. Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation. Stroke. 2008;39:1901-1910
3. Saposnik G, Cote R, Phillips S, Gubitz G, Bayer N, Minuk J, et al. Stroke outcome in those over 80: a multicenter cohort study across Canada. Stroke. 2008;39:2310-2317.
4. Fonarow GC, Reeves MJ, Zhao X, Olson DM, Smith EE, Saver JL, et al. Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke. Circulation. 2010;121:879-891.
5. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946-952.
6. Saposnik G, Kapral MK, Liu Y, Hall R, O'Donnell M, Raptis S, et al. IScore: a risk score to predict death early after hospitalization for an acute ischemic stroke. Circulation. 2011;123:739-749.
7. Saposnik G, Raptis S, Kapral MK, Liu Y, Tu JV, Mamdani M, et al. The iScore predicts poor functional outcomes early after hospitalization for an acute ischemic stroke. Stroke. 2011;42:3421-3428.
8. Saposnik G, Fang J, Kapral MK, Tu JV, Mamdani M, Austin P, et al. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke. Stroke. 2012;43:1315-1322.
9. Kapral MK, Silver FL, Richards JA, Lindsay MP, Fang J, Shi S, et al. Registry of the Canadian stroke network. Progress report 2001-2005. Toronto, Ontario, Canada: Institute for Clinical Evaluative Sciences; 2005.
10. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702-706.
11. Blacker DJ, Phatouros CC. Beyond IV thrombolysis for acute ischaemic stroke. Intern Med J. 2011;41:645.
12. Mitchell J, Lang E. Evidence-based emergency medicine. Update: effect of thrombolysis in acute ischemic stroke. Ann Emerg Med. 2011;57:e16-e17.
13. König IR, Ziegler A, Bluhmki E, Hacke W, Bath PM, Sacco RL, et al. Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke. 2008;39:1821-1826.
14. Weimar C, König IR, Kraywinkel K, Ziegler A, Diener HC; German Stroke Study Collaboration. Age and National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models. Stroke. 2004;35:158-162.
15. Kent DM, Selker HP, Ruthazer R, Bluhmki E, Hacke W. The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke. Stroke. 2006;37:2957-2962.
16. Solberg OG, Dahl M, Mowinckel P, Stavem K. Derivation and validation of a simple risk score for predicting 1-year mortality in stroke. J Neurol. 2007;254:1376-1383.
17. Strbian D, Meretoja A, Ahlhelm FJ, Pitkäniemi J, Lyrer P, Kaste M, et al. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score. Neurology. 2012;78:427-432.
18. Seet RC, Zhang Y, Wijdicks EF, Rabinstein AA. Relationship between chronic atrial fibrillation and worse outcomes in stroke patients after intravenous thrombolysis. Arch Neurol. 2011;68:1454-1458.
19. Awadh M, MacDougall N, Santosh C, Teasdale E, Baird T, Muir KW. Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation. Stroke. 2010;41:1990-1995.
20. Bateman BT, Schumacher HC, Boden-Albala B, Berman MF, Mohr JP, Sacco RL, et al. Factors associated with in-hospital mortality after administration of thrombolysis in acute ischemic stroke patients: an analysis of the nationwide inpatient sample 1999 to 2002. Stroke. 2006;37:440-446.
21. Zhang JB, Ding ZY, Yang Y, Sun W, Hai F, Sui XN, et al. Thrombolysis with alteplase for acute ischemic stroke patients with atrial fibrillation. Neurol Res. 2010;32:353-358.
22. Kimura K, Iguchi Y, Shibazaki K, Iwanaga T, Yamashita S, Aoki J. Iv t-pa therapy in acute stroke patients with atrial fibrillation. J Neurol Sci. 2009;276:6-8.
23. Kimura K, Iguchi Y, Yamashita S, Shibazaki K, Kobayashi K, Inoue T. Atrial fibrillation as an independent predictor for no early recanalization after iv-t-pa in acute ischemic stroke. J Neurol Sci. 2008;267:57-61.
24. Tu HT, Campbell BC, Christensen S, Collins M, De Silva DA, Butcher KS, et al. Pathophysiological determinants of worse stroke outcome in atrial fibrillation. Cerebrovasc Dis. 2010;30:389-395.
25. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-pa Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
26. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
27. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998;352:1245-1251.
28. The NINDS t-PA Stroke Study Group. Generalized efficacy of t-pa for acute stroke. Subgroup analysis of the ninds t-pa stroke trial. Stroke. 1997;28:2119-2125
29. Bluhmki E, Chamorro A, Dávalos A, Machnig T, Sauce C, Wahlgren N, et al. Stroke treatment with alteplase given 3. 0-4. 5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol. 2009;8:1095-1102.
30. Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third International Stroke Trial [IST-3]): A randomised controlled trial. Lancet. 2012; 379:2352-2363.
31. Frank B, Fulton R, Weimar C, Shuaib A, Lees KR; VISTA Collaborators. Impact of atrial fibrillation on outcome in thrombolyzed patients with stroke: evidence from the Virtual International Stroke Trials Archive (VISTA). Stroke. 2012;43:1872-1877.